MSB 3.21% $1.13 mesoblast limited

japan, page-4

  1. 96 Posts.
    lightbulb Created with Sketch. 2
    Hi Patienz,

    I reckon MSB, like all companies, put a positive spin on everything no matter what the news. As I've argued previously I would categorise the Diabetes result as a negative announcement as the therapy failed to reach clinical significance though this wasn't explicitly stated and it read as though the news was all good. You had to research the industry standards to discover the truth and, as you may have noticed, I got slammed on this forum for shining light on it!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.